Literature DB >> 21193222

SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.

Amélie Carbonnelle-Puscian1, Valérie Vidal, Ingrid Laurendeau, Laurence Valeyrie-Allanore, Dominique Vidaud, Ivan Bièche, Karen Leroy, Laurent Lantieri, Pierre Wolkenstein, Andreas Schedl, Nicolas Ortonne.   

Abstract

We investigated the expression of SOX9, a transcription factor linked to the hedgehog pathways, and desert hedgehog, previously shown to be expressed in a malignant peripheral nerve sheath tumor cell line, in neurofibromatosis 1 tumors (neurofibromas and malignant peripheral nerve sheath tumor), and in a group of sporadic spindle cell sarcomas. We found that SOX9 was expressed in Schwann cells from neurofibromatosis 1 tumors, and was significantly up-regulated in malignant peripheral nerve sheath tumor versus neurofibromas at the protein level (P < .0001) and in malignant peripheral nerve sheath tumor and plexiform neurofibroma as compared to diffuse tumors at the mRNA level (P = .002 and P = .009, respectively). SOX9, however, was not a specific feature of malignant peripheral nerve sheath tumor because a significant proportion of spindle cell sarcomas unrelated to neurofibromatosis 1 were also positive. Interestingly, within neurofibromas, SOX9 expression correlated to the histology mostly found in plexiform areas, whereas it was negative or weak in diffuse neurofibroma (P < .0001). In sporadic sarcomas, the proportion of positive cells was actually heterogeneous among cases. Desert hedgehog expression was mostly found in sarcomas (P = .0002), but diffuse staining was only seen in non-neurofibromatosis 1 tumors, whereas malignant peripheral nerve sheath tumor displayed only focal expression. Finally, we found no significant correlation between the expression of SOX9 and desert hedgehog, and neither SOX9 nor desert hedgehog expression was correlated to the histoprognostic grade in sarcomas. Altogether, these results indicate that, although not a specific feature of neurofibromatosis 1 tumors, SOX9 may play a role in the development of malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1 and does not appear to be linked to autocrine stimulation by the desert hedgehog signaling pathway.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193222     DOI: 10.1016/j.humpath.2010.02.020

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

1.  Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.

Authors:  Chun-Hui Zhou; Li-Ping Ye; Shi-Xing Ye; Yan Li; Xin-Yin Zhang; Xin-Yu Xu; Li-Yun Gong
Journal:  J Exp Clin Cancer Res       Date:  2012-03-03

2.  Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state.

Authors:  Veena Kochat; Ayush T Raman; Sharon M Landers; Ming Tang; Jonathan Schulz; Christopher Terranova; Jace P Landry; Angela D Bhalla; Hannah C Beird; Chia-Chin Wu; Yingda Jiang; Xizeng Mao; Rossana Lazcano; Swati Gite; Davis R Ingram; Min Yi; Jianhua Zhang; Emily Z Keung; Christopher P Scally; Christina L Roland; Kelly K Hunt; Barry W Feig; P Andrew Futreal; Patrick Hwu; Wei-Lien Wang; Alexander J Lazar; John M Slopis; Heather Wilson-Robles; Dominique J Wiener; Ian E McCutcheon; Brandan Wustefeld-Janssens; Kunal Rai; Keila E Torres
Journal:  Acta Neuropathol       Date:  2021-07-20       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.